...
首页> 外文期刊>Molecular cancer research: MCR >miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3.
【24h】

miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3.

机译:miRNA-223通过靶向肿瘤抑制因子EPB41L3促进胃癌的侵袭和转移。

获取原文
获取原文并翻译 | 示例
           

摘要

Traditional research modes aim to find cancer-specific single therapeutic target. Recently, emerging evidence suggested that some micro-RNAs (miRNA) can function as oncogenes or tumor suppressors. miRNAs are single-stranded, small noncoding RNA genes that can regulate hundreds of downstream target genes. In this study, we evaluated the miRNA expression patterns in gastric carcinoma and the specific role of miR-223 in gastric cancer metastasis. miRNA expression signature was first analyzed by real-time PCR on 10 paired gastric carcinomas and confirmed in another 20 paired gastric carcinoma tissues. With the 2-fold expression difference as a cutoff level, we identified 22 differential expressed mature miRNAs. Sixteen miRNAs were upregulated in gastric carcinoma, including miR-223, miR-21, miR-23b, miR-222, miR-25, miR-23a, miR-221, miR-107, miR-103, miR-99a, miR-100, miR-125b, miR-92, miR-146a, miR-214 and miR-191, and six miRNAs were downregulated in gastric carcinoma, including let-7a, miR-126, miR-210, miR-181b, miR-197, and miR-30aa-5p. After examining these miRNAs in several human gastric originated cell lines, we found that miR-223 is overexpressed only in metastatic gastric cancer cells and stimulated nonmetastatic gastric cancer cells migration and invasion. Mechanistically, miR-223, induced by the transcription factor Twist, posttranscriptionally downregulates EPB41L3 expression by directly targeting its 3'-untranslated regions. Significantly, overexpression of miR-223 in primary gastric carcinomas is associated with poor metastasis-free survival. These findings indicate a new regulatory mode, namely, specific miRNA, which is activated by its upstream transcription factor, could suppress its direct targets and lead to tumor invasion and metastasis. Mol Cancer Res; 9(7); 824-33. (c)2011 AACR.
机译:传统的研究模式旨在寻找癌症特异性的单一治疗靶标。最近,越来越多的证据表明,某些微RNA(miRNA)可以作为癌基因或抑癌基因。 miRNA是单链,小的非编码RNA基因,可以调节数百个下游靶基因。在这项研究中,我们评估了miRNA在胃癌中的表达模式以及miR-223在胃癌转移中的特定作用。首先通过实时PCR在10对配对的胃癌上分析miRNA的表达特征,并在另外20对配对的胃癌组织中进行确认。以2倍表达差异作为临界水平,我们鉴定出22种差异表达的成熟miRNA。胃癌中有16种miRNA上调,包括miR-223,miR-21,miR-23b,miR-222,miR-25,miR-23a,miR-221,miR-107,miR-103,miR-99a,miR -100,miR-125b,miR-92,miR-146a,miR-214和miR-191,以及六个miRNA在胃癌中下调,包括let-7a,miR-126,miR-210,miR-181b,miR -197和miR-30aa-5p。在几种人类胃源性细胞系中检查了这些miRNA后,我们发现miR-223仅在转移性胃癌细胞中过表达,并刺激了非转移性胃癌细胞的迁移和侵袭。从机理上讲,由转录因子Twist诱导的miR-223通过直接靶向3B非翻译区来转录后下调EPB41L3的表达。值得注意的是,miR-223在原发性胃癌中的过度表达与无转移生存期差有关。这些发现表明,一种新的调控模式,即由其上游转录因子激活的特异性miRNA,可以抑制其直接靶标并导致肿瘤的侵袭和转移。分子癌症研究; 9(7); 824-33。 (c)2011年美国机修协会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号